Infinity Pharmaceuticals, Inc.

INFIQ · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$38,313$80,726$28,593$22,260
Short-Term Investments$0$0$5,515$20,184
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,989$1,542$1,912$2,137
Total Curr. Assets$40,302$82,268$36,020$44,581
Property Plant & Equip (Net)$1,497$2,305$3,129$3,903
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$158$158$165$315
Tax Assets$0$0$0$0
Other NC Assets$194$54$5$215
Total NC Assets$1,849$2,517$3,299$4,433
Other Assets$0$0$0$0
Total Assets$42,151$84,785$39,319$49,014
Liabilities
Payables$4,405$2,320$2,982$1,621
Short-Term Debt$593$1,416$1,337$381
Tax Payable$0$0$0$0
Deferred Revenue$0$9,151$5,896$6,848
Other Curr. Liab.$8,630$413$832$848
Total Curr. Liab.$13,628$13,300$11,047$9,698
LT Debt$47,537$49,644$22,995$31,552
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$37$270$28,266$38
Total NC Liab.$47,574$49,914$51,261$31,590
Other Liabilities$0$0$0$0
Cap. Leases$917$1,436$1,925$2,307
Total Liabilities$61,202$63,214$62,308$41,288
Equity
Pref Stock$0$0$0$0
Common Stock$89$89$64$57
Retained Earnings-$855,952-$811,583-$766,321-$725,829
AOCI$0$0-$1$12
Other Equity$836,812$833,065$743,269$733,486
Total Equity-$19,051$21,571-$22,989$7,726
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$42,151$84,785$39,319$49,014
Net Debt$9,817-$29,666-$4,261$9,673